Antibody-drug Conjugate Information
General Information of This Antibody-drug Conjugate (ID: DRG0EFIRN)
| ADC Name |
AU2020291014A1 IC-6
|
|||||
|---|---|---|---|---|---|---|
| Synonyms |
IC-6
Click to Show/Hide
|
|||||
| Organization |
BOLT BIOTHERAPEUTICS, INC.
|
|||||
| Drug Status |
Investigative
|
|||||
| Drug-to-Antibody Ratio |
0.5
|
|||||
| Antibody Name |
Trastuzumab
|
Antibody Info | ||||
| Antigen Name |
Receptor tyrosine-protein kinase erbB-2 (HER2)
|
Antigen Info | ||||
| Payload Name |
Undisclosed
|
|||||
| Linker Name |
Undisclosed
|
|||||
| Conjugate Type |
Random conjugation through nucleophilic lysines
|
|||||
| Combination Type |
BzL-8
|
|||||